Skip to content
10-K

Annual Report

TANDEM DIABETES CARE INC TNDM

0001438133-26-000010

← back to feed
Filed
Feb 19, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 16, 2026 68.33M sh
Shares Diluted FY 2025 · Dec 31, 2025 68.01M sh
Shares Diluted FY 2025 · Dec 31, 2025 67.29M sh
Shares Diluted FY 2025 · Dec 31, 2024 66.16M sh
Shares Diluted FY 2025 · Dec 31, 2024 65.45M sh
Shares Diluted FY 2025 · Dec 31, 2023 64.97M sh
Stock Repurchased FY 2025 · Dec 31, 2025 $0
Stock Repurchased FY 2025 · Dec 31, 2024 $30M
Stock Repurchased FY 2025 · Dec 31, 2023 $0
Capex FY 2025 · Dec 31, 2025 $19.95M
Capex FY 2025 · Dec 31, 2024 $19.23M
Capex FY 2025 · Dec 31, 2023 $26.8M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$9.72M
Operating Cash Flow FY 2025 · Dec 31, 2024 $24.23M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$31.81M
Long Term Debt FY 2025 · Dec 31, 2025 $310.04M
Long Term Debt FY 2025 · Dec 31, 2024 $308.27M
Short Term Investments FY 2025 · Dec 31, 2025 $202.03M
Short Term Investments FY 2025 · Dec 31, 2024 $369.1M
Cash And Equivalents FY 2025 · Dec 31, 2025 $90.63M
Cash And Equivalents FY 2025 · Dec 31, 2024 $69.23M
Stockholders Equity FY 2025 · Dec 31, 2025 $155.17M
Stockholders Equity FY 2025 · Dec 31, 2024 $263.1M
Stockholders Equity FY 2025 · Dec 31, 2023 $313.63M
Stockholders Equity FY 2025 · Dec 31, 2022 $439.95M
Current Liabilities FY 2025 · Dec 31, 2025 $242.72M
Current Liabilities FY 2025 · Dec 31, 2024 $247.05M
Total Liabilities FY 2025 · Dec 31, 2025 $725.94M
Total Liabilities FY 2025 · Dec 31, 2024 $704.56M
Current Assets FY 2025 · Dec 31, 2025 $618.14M
Current Assets FY 2025 · Dec 31, 2024 $724.49M
Total Assets FY 2025 · Dec 31, 2025 $881.11M
Total Assets FY 2025 · Dec 31, 2024 $967.66M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.01
Eps Diluted FY 2025 · Dec 31, 2025 −$3.04
Eps Diluted FY 2025 · Dec 31, 2024 $0.01
Eps Diluted FY 2025 · Dec 31, 2024 −$1.47
Eps Diluted FY 2025 · Dec 31, 2023 −$3.43
Eps Basic FY 2025 · Dec 31, 2025 −$0.01
Eps Basic FY 2025 · Dec 31, 2025 −$3.04
Eps Basic FY 2025 · Dec 31, 2024 $0.01
Eps Basic FY 2025 · Dec 31, 2024 −$1.47
Eps Basic FY 2025 · Dec 31, 2023 −$3.43
Sga Expense FY 2025 · Dec 31, 2025 $444.99M
Sga Expense FY 2025 · Dec 31, 2024 $389.82M
Sga Expense FY 2025 · Dec 31, 2023 $352.5M
Net Income FY 2025 · Dec 31, 2025 −$589K
Net Income FY 2025 · Dec 31, 2025 −$204.71M
Net Income FY 2025 · Dec 31, 2024 $755K
Net Income FY 2025 · Dec 31, 2024 −$96.03M
Net Income FY 2025 · Dec 31, 2023 −$222.61M
Operating Income FY 2025 · Dec 31, 2025 $8.29M
Operating Income FY 2025 · Dec 31, 2025 −$187.26M
Operating Income FY 2025 · Dec 31, 2024 −$581K
Operating Income FY 2025 · Dec 31, 2024 −$99.13M
Operating Income FY 2025 · Dec 31, 2023 −$233.23M
Gross Profit FY 2025 · Dec 31, 2025 $167.46M
Gross Profit FY 2025 · Dec 31, 2025 $546.01M
Gross Profit FY 2025 · Dec 31, 2024 $157.46M
Gross Profit FY 2025 · Dec 31, 2024 $489.57M
Gross Profit FY 2025 · Dec 31, 2023 $367.69M
Cost Of Revenue FY 2025 · Dec 31, 2025 $468.72M
Cost Of Revenue FY 2025 · Dec 31, 2024 $450.63M
Cost Of Revenue FY 2025 · Dec 31, 2023 $380.03M
Revenue FY 2025 · Dec 31, 2025 $290.38M
Revenue FY 2025 · Dec 31, 2025 $1.01B
Revenue FY 2025 · Dec 31, 2024 $282.65M
Revenue FY 2025 · Dec 31, 2024 $940.2M
Revenue FY 2025 · Dec 31, 2023 $747.72M